Skip to main content
SpringerLink
Log in

Adalimumab/etanercept/methotrexate

Various toxicities following off-label use: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hoffmann JHO, et al. Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-alpha antagonists versus TNF-alpha antagonists alone in psoriatic patients. Journal of Dermatology 48: 835-843, No. 6, Jun 2021. Available from: URL: https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.15754

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/etanercept/methotrexate. Reactions Weekly 1889, 20 (2022). https://doi.org/10.1007/s40278-022-08699-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-08699-y

Search

Navigation